Cytogenetics of benign breast lesions

Breast Cancer Research and Treatment

Volumn 51, Issue 1, 1998, Pages 1-15

  Lundin, Catarina ^a   Mertens, Fredrik ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Benign breast lesions; Breast cancer; Cancer risk; Chromosomes; Cytogenetics; Molecular genetics

Indexed keywords

BREAST ADENOMA; BREAST CANCER; BREAST LESION; CHROMOSOME 1Q; CHROMOSOME 3; CHROMOSOME 3P; CHROMOSOME ABERRATION; CYSTOSARCOMA PHYLLOIDES; CYTOGENETICS; FEMALE; FIBROADENOMA; GENE DELETION; GENE INSERTION; GENE REARRANGEMENT; HISTOLOGY; HUMAN; INVASIVE CARCINOMA; KARYOTYPE; PAPILLOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK; TRISOMY 18; TRISOMY 20; TRISOMY 7; TUMOR SUPPRESSOR GENE;

BREAST DISEASES; BREAST NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMANS; KARYOTYPING;

EID: 0031769123     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006009531378     Document Type: Review

References (116)

1. Mark J, Levan G, Mitelman F: Identification by fluorescence of the G chromosome lost in human meningiomas. Hereditas 71: 163-168, 1972
2. Zang KD, Singer H: Chromosomal constitution of meningiomas. Nature 216: 84-85, 1967
3. Heim S, Mitelman F: Cancer Cytogenetics, 2nd ed. Wiley-Liss, New York, 1995
4. Mitelman F: Catalog of Chromosome Aberrations in Cancer. 6th ed. Wiley-Liss, New York (in press), 1998
5. Dembinski A, Bridge JA, Neff JR, Berger C, Sandberg AA: Trisomy 2 in proliferative fasciitis. Cancer Genet Cytogenet 60: 27-30, 1992
6. Roque L, Gomes P, Correia C, Soares P, Soares J, Castedo S: Thyroid nodular hyperplasia: Chromosomal studies in 14 cases. Cancer Genet Cytogenet 69: 31-34, 1993
7. Johansson B, Heim S, Mandahl N, Mertens F, Mitelman F: Trisomy 7 in nonneoplastic cells. Genes Chromosomes Cancer 6: 199-205, 1993
8. Elfving P, Åman P, Mandahl N, Lundgren R, Mitelman F: Trisomy 7 in nonneoplastic epithelial kidney cells. Cytogenet Cell Genet 69: 90-96, 1995
9. Broberg K, Limon J, Pålsson E, Lindstrand A, Toksvig-Larsen S, Mandahl N. Mertens F: Clonal chromosome aberrations are present in vivo in synovia and osteophytes from patients with osteoarthritis. Hum Genet 101: 295-298, 1997
10. Jin C, Jin Y, Wennerberg J, Åkervall J, Grenthe B, Mandahl N, Heim S, Mitelman F, Mertens F: Clonal chromosome aberrations accumulate with age in upper aerodigestive tract mucosa. Mutat Res 374: 63-72, 1997
11. Love SM, Gelman RS, Silen W: Fibrocystic 'disease' of the breast - a nondisease? N Engl J Med 307: 1010-1014, 1982
12. Consensus Statement by the Cancer Committee of the College of American Pathologists: Is 'fibrocystic disease' of the breast precancerous? Arch Pathol Lab Med 110: 171-173, 1986
13. Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312: 146-151, 1985
14. Rosai J: Borderline epithelial lesions of the breast. Am J Surg Pathol 15: 209-221, 1991
15. Schnitt SJ, Connolly JL, Tavassolli FA, Fechner RE, Kempson RL, Gelman R, Page DL: Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol 16: 1133-1143, 1992
16. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990
17. Frykberg ER, Bland KI: In situ breast carcinoma. Adv Surg 26: 29-72, 1993
18. Frantz VK, Pickren JW, Melcher GW, Auchincloss H: Incidence of chronic cystic disease in so-called 'normal breasts'. A study based on 225 postmortem examinations. Cancer 4: 762-783, 1951
19. Dixon JM: Cystic disease and fibroadenoma of the breast: Natural history and relation to breast cancer risk. Br Mod Bull 47: 258-271, 1991
20. Dupont WD, Page DL, Pari FF, Vnencak-Jones CL, Plummer WD, Rados MS, Schuyler PA: Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 331: 10-15, 1994
21. Houlihan MJ: Fibroadenoma and hamartoma. In: Harris JR. Morrow M, Lippman ME, Hellman S (eds) Diseases of the Breast. Lippincott-Raven, Philadelphia, 1996, pp 45-48
22. Gadd MA: Papillary lesions. In: Harris JR, Morrow M, Lippman ME, Hellman S (eds) Diseases of the Breast. Lippincott-Raven, Philadelphia, 1996, pp 42-45
23. Page DL, Salhany KE, Jansen RA, Dupont WD: Subsequent breast carcinoma risk after biopsy with atypia in breast papilloma. Cancer 78: 258-266, 1996
24. Petrek JA: Phyllodes tumors. In: Harris JR, Morrow M, Lippman ME, Hellman S (eds) Diseases of the Breast. Lippincott-Raven, Philadelphia, 1996, pp 863-869
25. Calabrese G, Di Virgilio C, Cianchetti E, Franchi GP, Stuppia L, Parruti G, Bianchi PG, Palka G: Chromosome abnormalities in breast fibroadenomas. Genes Chromosomes Cancer 3: 202-204, 1991
26. Fletcher JA, Pinkus GS, Weidner N, Morton CC: Lineage-restricted clonality in biphasic solid tumors. Am J Pathol 138: 1199-1207, 1991
27. Stephenson CF, Davis RI, Moore GE, Sandberg AA: Cytogenetic and fluorescence in situ hybridization analysis of breast fibroadenomas. Cancer Genet Cytogenet 63: 32-36, 1992
28. Belda F, Lester SC, Pinkus JL, Pinkus GS, Fletcher JA: Lineage restricted chromosome translocation in a benign fibrous tumor of the breast. Hum Pathol 24: 923-927, 1993
29. Leuschner E, Mayer-Bolte K, Caselitz J, Bartnitzke S, Bullerdiek J: Fibroadenoma of the breast showing a translocation (6;14), a ring chromosome and two markers involving parts of chromosome 11. Cancer Genet Cytogenet 76: 145-147, 1994
30. Ozisik YY, Meloni AM, Stephenson CF, Peier A, Moore GE, Sandberg AA: Chromosome abnormalities in breast fibroadenomas. Cancer Genet Cytogenet 77: 125-128, 1994
31. Dietrich CU, Pandis N, Teixeira MR, Bardi G, Gerdes A-M, Andersen JA, Heim S: Chromosome abnormalities in benign hyperproliferative disorders of epithelial and stromal breast tissue. Int J Cancer 60: 49-53, 1995
32. Rohen C, Staats B, Bonk U, Bartnitzke S, Bullerdiek J: Significance of clonal chromosome aberrations in breast fibroadenomas. Cancer Genet Cytogenet 87: 152-155, 1996
33. Staats B, Bonk U, Wanschura S, Hanisch P, Schoenmakers EFPM, Van de Ven WJM, Bartnitzke S, Bullerdiek J: A fibroadenoma with a t(4;12)(q27;q15) affecting the HMGI-C gene, a member of the high mobility group protein gene family. Breast Cancer Res Treat 38: 299-303, 1996
34. Petersson C, Pandis N, Rizou H, Mertens F, Dietrich CU, Adeyinka A, Idvall I, Bondeson L, Georgrou G, Ingvar C, Heim S, Mitelman F: Karyotypic abnormalities in fibroadenomas of the breast. Int J Cancer 70: 282-286, 1997
35. Birdsall SH, MacLenna KA, Gusterson BA: t(6;12) (q23;q13) and t(10;16)(q22;p11) in a phyllodes tumor of the breast. Cancer Genet Cytogenet 60: 74-77, 1992
36. Birdsall SH, Summersgill BM, Egan M, Fentiman IS, Gusterson BA, Shipley JM: Additional copies of 1q in sequential samples from a phyllodes tumor of the breast. Cancer Genet Cytogenet 83: 111-114, 1995
37. Dietrich CU, Pandis N, Bardi G, Teixeira MR, Soukhikh T, Petersson C, Andersen JA, Heim S: Karyotypic changes in phyllodes tumors of the breast. Cancer Genet Cytogenet 78: 200-206, 1994
38. Dietrich CU, Pandis N, Rizou H, Petersson C, Bardi G, Qvist H, Apostolikas N, Bøhler PJ, Andersen JA, Idvall I, Mitelman F, Heim S: Cytogenetic findings in phyllodes tumors of the breast: Karyotypic complexity differentiates between malignant and benign tumors. Hum Pathol 28: 1379-1382, 1997
39. Dal Cin P, Moreman P, de Wever I, Van den Berghe H: Is i(1)(q10) a chromosome marker in phyllodes tumor of the breast? Cancer Genet Cytogenet 83: 174-175, 1995
40. Bullerdiek J, Leuschner E, Taquia E, Bonk U, Bartnitzke S: Trisomy 8 as a recurrent clonal abnormality in breast cancer? Cancer Genet Cytogenet 65: 64-67, 1993
41. Rohen C, Bonk U, Staats B, Bartnitzke S, Bullerdiek J: Two human breast tumors with translocations involving 12q13-15 as the sole cytogenetic abnormality. Cancer Genet Cytogenet 69: 68-71, 1993
42. Petersson C, Johansson B, Pandis N, Gorunova L, Ingvar C, Idvall I, Mandahl N, Mitelman F: Clonal chromosome aberrations in fibrocystic disease associated with increased risk of cancer. Int J Oncol 5: 1207-1210, 1994
43. Dal Cin P, Moerman P, Christiaens MR, Van den Berghe H: Observation of a deletion of the long arm of chromosome 6 in benign fibrocystic disease of the breast constitutes a challenging problem. Genes Chromosomes Cancer 16: 68-71, 1996
44. Petersson Lundin C, Mertens F, Rizou H, Idvall I, Georgiou G, Ingvar C, Pandis N: Cytogenetic changes in benign proliferative as well as nonproliferative lesions of the breast. Cancer Genet Cytogenet (in press), 1998
45. Petersson Lundin C, Mertens F, Ingvar C, Idvall I, Pandis N: Trisomy 16 as the primary chromosome aberration in a papilloma of the breast. Cancer Genet Cytogenet (in press), 1998
46. Dietrich CU, Pandis N, Andersen JA, Heim S: Chromosome abnormalities in adenolipomas of the breast: Karyotypic evidence that the mesenchymal component constitutes the neoplastic parenchyma. Cancer Genet Cytogenet 72: 146-150, 1994
47. Rohen C, Caselitz J, Stern C, Wanschura S, Schoenmakers EFPM, Van de Ven WJM, Bartnitzke S, Bullerdiek J: A hamartoma of the breast with an aberration of 12q mapped to the MAR region by fluorescence in situ hybridization. Cancer Genet Cytogenet 84: 82-84, 1995
48. Dietrich CU, Pandis N, Bardi G, Hägerstrand I, Andersen JA, Mitelman F, Heim S: Rearrangement of chromosomal bands 3p13-14 in two hamartomas of the breast. Int J Oncol 6: 559-561, 1995
49. Dal Cin P, Wanschura S, Christiaens M-R, Van den Berghe I, Moerman P, Polito P, Kazmierczak B, Bullerdiek J, Van den Berghe H: Hamartoma of the breast with involvement of 6p21 and rearrangement of HMGIY. Genes Chromosomes Cancer 20: 90-92, 1997
50. Birdsall SH, Shipley JM, Summersgill BM, Black AJM, Jackson P, Kissin MW. Gusterson BA: Cytogenetic findings in a case of nodular fasciitis of the breast. Cancer Genet Cytogenet 81: 166-168, 1995
51. Petersson C, Pandis N, Mertens F, Adeyinka A, Ingvar C, Ringberg A, Idvall I, Bondeson L, Borg Å, Olsson H, Kristoffersson U, Mitelman F: Chromosome aberrations in prophylactic mastectomies from women belonging to breast cancer families. Genes Chromosomes Cancer 16: 185-188, 1996
52. Teixeira MR, Pandis N, Gerdes A-M, Dietrich CU, Bardi G, Andersen JA, Graversen HP, Mitelman F, Heim S: Cytogenetic abnormalities in an in situ ductal carcinoma and five prophylactically removed breasts from members of a family with hereditary breast cancer. Breast Cancer Res Treat 38: 177-182, 1996
53. Wolman SR, Smith HS, Stampfer M, Hackett AJ: Growth of diploid cells from breast cancers. Cancer Genet Cytogenet 16: 49-64, 1985
54. Zhang R, Wiley J, Howard SP, Meisner LF, Gould MN: Rare clonal karyotypic variants in primary cultures of human breast carcinoma cells. Cancer Res 49: 444-449, 1989
55. Geleick D, Müller H, Matter A, Torhorst J, Regenass U: Cytogenetics of breast cancer. Cancer Genet Cytogenet 46: 217-229, 1990
56. Teixeira MR, Pandis N, Bardi G, Andersen JA, Heim S: Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer. Cancer Res 56: 855-859, 1996
57. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS: Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274: 2057-2059, 1996
58. Pavelic ZP, Pavelic L, Lower EE, Gapany M, Gapany S, Barker EA, Preisler HD: c-myc, c-erbB-2, and Ki-67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma. Cancer Res 52: 2597-2602, 1992
59. Page DL, Dupont WD: Anatomic indicators (histologic and cytologic) of increased breast cancer risk. Breast Cancer Res Treat 28: 157-166, 1993
60. Skolnick MH, Cannon-Albright LA, Goldgar DE, Ward JH, Marshall CJ, Schumann GB, Hogle H, McWhorter WP, Wright EC, Tran TD, Bishop DT, Kushner JP, Eyre HJ: Inheritance of proliferative breast disease in breast cancer kindreds. Science 250: 1715-1720, 1990
61. Mandahl N, Höglund M, Mertens F, Rydholm A, Willén H, Brosjö O, Mitelman F: Cytogenetic aberrations in 188 benign and borderline adipose tissue tumors. Genes Chromosomes Cancer 9: 207-215, 1994
62. Nilbert M, Heim S: Uterine leiomyoma cytogenetics. Genes Chromosomes Cancer 2: 3-13, 1990
63. Bullerdiek J, Wobst G, Meyer-Bolte K, Chilla R, Haubrich J, Thode B, Bartnitzke S: Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas: Correlation to occurrence, histological subtype, and in vitro cellular behavior. Cancer Genet Cytogenet 65: 27-31, 1993
64. Ashar HR, Schoenberg Fejzo M, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S, Morton CC, Chada K: Disruption of the architectural factor HMGI-C: DNA-binding at hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82: 57-65, 1995
65. Schoenmakers EFPM, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven WJM: Recurrent rearrangements in the high mobility group protein gene. HMGI-C, in benign mesenchymal tumours. Nat Genet 10: 436-443, 1995
66. Van de Ven WJM, Schoenmakers EFPM, Wanschura S, Kazmierczak B, Kools PFJ, Geurts JMW, Bartnitzke S, Van den Berghe H, Bullerdiek J: Molecular characterization of MAR, a multiple aberration region on chromosome segment 12q13-q15 implicated in various solid tumors. Genes Chromosomes Cancer 12: 296-303, 1995
67. Kazmierczak B, Wanschura S, Rommel B, Bartnitzke S, Bullerdiek J: Ten pulmonary chondroid hamartomas with chromosome 6p21 breakpoints within the HMG-I(Y) gene or its immediate surroundings. J Natl Cancer Inst 88: 1234-1236, 1996
68. Kazmierczak B, Bol S, Wanschura S, Bartnitzke S, Bullerdiek J: PAC clone containing the HMGI(Y) gene spans the breakpoint of a 6p21 translocation in a uterine leiomyoma cell line. Genes Chromosomes Cancer 17: 191-193, 1996
69. Noguchi S, Yokouchi H, Aihara T, Motomura K, Inaji H, Imaoka S, Koyama H: Progression of fibroadenoma to phyllodes tumor demonstrated by clonal analysis. Cancer 76: 1779-1785, 1995
70. Lu Y-J, Birdsall S, Osin P, Gusterson B, Shipley J: Phyllodes tumors of the breast analyzed by comparative genomic hybridization and association of increased 1q copy number with stromal overgrowth and recurrence. Genes Chromosomes Cancer 20: 275-281, 1997
71. Ried T, Just KE, Holtgreve-Grez H, du Manoir S, Speicher MR, Schröck E, Latham C, Biegen H, Zetterberg A, Cremer T, Auer G: Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadeomas and diploid and aneuploid carcinomas. Cancer Res 55: 5415-5423, 1995
72. Micale MA, Visscher DW, Gulino SE, Wolman SR: Chromosomal aneuploidy in proliferative breast disease. Hum Pathol 25: 29-35, 1994
73. Verdoodt B, Castelain P, Bourgain C, Kirsch-Volders M: Aneuploidy for chromosome 1 and overall DNA content in benign and malignant breast disease. Cancer Genet Cytogenet 78: 53-63, 1994
74. Sneige N, Sahin A, Dinh M, El-Naggar A: Interphase cytogenetics in mammographically detected breast lesions. Hum Pathol 27: 330-335, 1996
75. Visscher DW, Wallis TL, Crissman JD: Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics. Cancer 77: 315-320, 1996
76. Leuschner E, Staats B, Gohla G, Bartnitzke S, Bonk U, Bullerdiek J: Fluorescence in situ hybridization studies on breast tumor samples for distinguishing between different subsets of breast cancer. Acta Cytol 40: 151-157, 1996
77. Papamichalis G, Francia K, Karachaliou FE, Anastasiades OT, Spandidos DA: Expression of the c-myc oncoprotein in human metaplastic epithelial cells of fibrocystic disease. Anticancer Res 8: 1217-1222, 1988
78. Spandidos DA, Pintzas A, Kakkanas A, Yiagnisis M, Mahera H, Patra E, Agnantis NJ: Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue. Anticancer Res 7: 1299-1304, 1987
79. Whittaker JL, Walker RA, Varley JM: Differential expression of cellular oncogenes in benign and malignant human breast tissue. Int J Cancer 38: 651-655, 1986
80. Hehir DJ, McGreal G, Kirwan WO, Kealy W, Brady MP: C-myc oncogene expression: A marker for females at risk of breast carcinoma. J Surg Oncol 54: 207-210, 1993
81. Escot C, Simony-Lafontaine J, Maudelonde T, Puech C, Pujol H, Rochefort H: Potential value of increased MYC but not ERBB2 RNA levels as a marker of high-risk mastopathies. Oncogene 8: 969-974, 1993
82. Lizard-Nacol S, Lidereau R, Collin F, Arnal M, Hahnel L, Roignot P, Cuisenier J, Guerrin J: Benign breast disease: Absence of genetic alterations at several loci implicated in breast cancer malignancy. Cancer Res 55: 4416-4419, 1995
83. Visscher DW, Wallis T, Awussah S, Mohamed A, Crissman JD: Evaluation of MYC and chromosome 8 copy number in breast carcinoma by interphase cytogenetics. Genes Chromosomes Cancer 18: 1-7, 1997
84. Varley JM, Swallow JE, Brammar WJ, Whittaker JL, Walker RA: Alterations to either c-erbB-2 (neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis. Oncogene 1: 423-430, 1987
85. Gusterson BA, Machin LG, Gullick WJ, Gibbs NM, Powles TJ, Elliott C, Ashley S, Monaghan P, Harrison S: c-erbB-2 expression in benign and malignant breast disease. Br J Cancer 58: 453-457, 1988
86. Coene ED, Schelfhout V, Winkler RA, Schelfhout A-M, Van Roy N, Grooteclaes M, Speleman F, De Potter CR: Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer. Virchows Arch 430: 365-372, 1997
87. Inaji H, Koyama H, Motomura K, Noguchi S, Mori Y, Kimura Y, Sugano K, Ohkura H: ErbB-2 protein levels in nippic discharge: Role in diagnosis of early breast cancer. Tumor Biol 14: 271-278, 1993
88. Millikan R, Hulka B, Thor A, Zhang Y, Edgerton S, Zhang X, Pei H, He M, Wold L, Mellon LJ, Ballard D, Conway K. Liu ET: p53 mutations in benign breast tissue. J Clin Oncol 13: 2293-2300, 1995
89. Biéche I, Lidereau R: Genetic alterations in breast cancer. Genes Chromosomes Cancer 14: 227-251, 1995
90. Zhang S-Y, Caamano J, Cooper F, Guo X, Klein-Szanto AJP: Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol 102: 695-698, 1994
91. O'Connell P, Pekkel V, Fuqua S, Osborne CK, Allred DC: Molecular genetic studies of early breast cancer evolution. Breast Cancer Res Treat 32: 5-12, 1994
92. Lalle P, De Latour M, Rio P, Bignon Y-J: Detection of allelic losses on 17q12-q21 chromosomal region in benign lesions and malignant tumors occurring in a familial context. Oncogene 9: 437-442, 1994
93. Lakhani SR, Collins N, Stratton MR, Sloane JP: Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol 48: 611-615, 1995
94. Lakhani SR, Slack DN, Hamoudi RA, Collins N, Stratton MR, Sloane JP: Detection of allelic imbalance indicates that a proportion of mammary hyperplasias of usual type are clonal, neoplastic proliferations. Lab Invest 74: 129-135, 1996
95. Tsuda H, Uei Y, Fukutomi T, Hirohashi S: Different incidence of loss of heterozygosity on chromosome 16q between intraductal papilloma and intracystic papillary carcinoma of the breast. Jpn J Cancer Res 85: 992-996, 1994
96. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B: Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-708, 1989
97. Thor A, Moore II DH, Edgerton SM, Kawasaki ES, Reihsaus F, Lynch HT, Marcus JN, Schwartz L, Chen L-C, Mayall BH, Smith HS: Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers. J Natl Cancer Inst 84: 845-855, 1992
98. Seth A, Palli D, Mariano JM, Metcalf R, Venanzoni MC, Bianchi S, Kottaridis SD, Papas TS: p53 gene mutations in women with breast cancer and a previous history of benign breast disease. Eur J Cancer 30A: 808-812, 1994
99. Koutselini H, Malliri A, Field JK, Spandidos DA: p53 expression in cytologic specimens from benign and malignant breast lesions. Anticancer Res 11: 1415-1420, 1991
100. Di Martino L, Benini E, Faranda A, De Montis B, Murenu G, Ferreli A, Daidone MG, Silvestrini R: P53, Bcl-2 expression and cell proliferation in benign breast lesions. Int J Oncol 8: 1053-1057, 1996
101. Pandis N, Bardi G, Mitelman F, Heim S: Deletion of the short arm of chromosome 3 in breast tumors. Genes Chromosomes Cancer 18: 241-245, 1997
102. Panagopoulos I, Pandis N, Thelin S. Petersson C, Mertens F, Borg Å, Kristoffersson U, Mitelman F, Aman F: The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14. Cancer Res 56: 4871-4875, 1996
103. Sahlin P, Mark J, Stenman G: Submicroscopic deletions of 3p sequences in pleomorphic adenomas with t(3;8) (p21;q12). Genes Chromosomes Cancer 10: 256-261, 1994
104. Hoglund M, Johansson B, Pedersen-Bjergaard J, Marynen P. Mitelman F: Molecular characterization of 12p abnormalities in hematologic malignancies: Deletion of KIP1, rearrangement of TEL, and amplification of CCND2. Blood 87: 324-330, 1996
105. Kok K, Naylor SL, Buys CHCM: Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res 71: 27-92, 1997
106. Mertens F, Johansson B, Hoglund M, Mitelman F: Chromosomal imbalance maps of malignant solid tumors: A cytogenetic survey of 3185 neoplasms. Cancer Res 57: 2765-2780, 1997
107. Ohla M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T. Croce CM, Huebner K: The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84: 587-597, 1996
108. Negrini M, Monaco C, Vorechovsky I, Ohta M, Druck T, Baffa R, Huebner K, Croce CM: The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res 56: 3173-3179, 1996
109. Ahmadian M, Wistuba H, Fong KM, Behrens C, Kodagoda DR, Saboorian MH, Shay J, Tomlinson GE, Blum J, Minna JD, Gazdar AF: Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands. Cancer Res 57: 3664-3668, 1997
110. Panagopoulos I, Thelin S, Mertens F, Mitelman F, Åman P: Variable FHIT transcripts in non-neoplastic tissues. Genes Chromosomes Cancer 19: 215-219, 1997
111. Van den Berg A, Draaijers TG, Kok K, Timmer T, Van der Veen AY, Veldhuis PMJF, de Leij L, Gerhartz CD, Naylor SL, Smith DI, Buys CHCM: Normal FHIT transcripts in renal cell cancer-and lung cancer-derived cell lines, including a cell line with a homozygous deletion in the FRA3B region. Genes Chromosomes Cancer 19: 220-227, 1997
112. Pandis N, Jin Y, Gorunova L, Petersson C, Bardi G, Idvall I, Johansson B, Ingvar C, Mandahl N, Mitelman F, Heim S: Chromosome analysis of 97 primary breast carcinomas: Identification of eight karyotypic subgroups. Genes Chromosomes Cancer 12: 173-185, 1995
113. Mertens F, Willén H, Rydholm A, Brosjö O, Carlén B, Mitelman F, Mandahl N: Trisomy 20 is a primary chromosome aberration in desmoid tumors. Int J Cancer 63: 527-529, 1995
114. Heim S, Teixeira MR, Dietrich CU, Pandis N: Cytogenetic polyclonality in tumors of the breast. Cancer Genet Cytogenet 95: 16-19, 1997
115. Pandis N, Bardi G, Heim S: Interrelationship between methodological choices and conceptual models in solid tumor cytogenetics. Cancer Genet Cytogenet 76: 77-84, 1994
116. Mitelman F, Mertens F, Johansson B: A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15: 417-474, 1997